Just Answers
#1 in Business Subscribe Email Print

You are here: Home > Writing and Speaking > Article Marketing > Article Marketing - Should You Use Article Submission Software?

Tags

  • involved
  • devices
  • drugs
  • biological product
  • combination products
  • companies involved

  • Links

  • Reincarnation - Is It Credible?
  • How To Win a Poker Tournament
  • Should You Hire a Professional Copywriter?
  • Just Answers - Article Marketing - Should You Use Article Submission Software?

    I see Article Software advertised that will send your article to hundreds of
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    article directories. How effective is this? What about duplicate content?

    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    have tried two or three different pieces of Article Software. It works--I c
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    n send out fifty articles in an hour. The funny thing is that when I send th
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    se articles out using Article Software, I find that I don't get as many link
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    from them as if I personally submit them, or I pay somebody to personally s
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    bmit them. I don't know why. I'm a big results person.

    If something’s not w
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    rking--a lot of times I won't even ask why. I'll just move on to the next th
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ng. Now, that's not always the wisest thing to do. But, right now, given my
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    usiness structure, I really apply that eighty-twenty principle. Eighty-perce
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    t of my results come from twenty percent of the work that I do. And right no
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    w, rather than focusing on the eighty percent that doesn't produce results,
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    just multiply the twenty percent.

    Right now what's working for me is perso
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ally submitting them by hand. I'm sure it's boring. I'm sure it takes time.
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ut that's how I do it. Am I telling you that all of the article-software out
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    there is no good?

    No. I don't understand why it happens. Perhaps, some of t
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    e better article directories can recognize whether it's coming in from some
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    achine? I'm not technical so I don't know. Maybe they just don't put as much
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    priority on the articles? I don't know. All that I know is that it hasn't wo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ked for me. Nothing against the software itself. It just doesn't work for me


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justanswers.org.ua/article/158662/justanswers-Article-Marketing--Should-You-Use-Article-Submission-Software.html">Article Marketing - Should You Use Article Submission Software?</a>

    BB link (for phorums):
    [url=http://www.justanswers.org.ua/article/158662/justanswers-Article-Marketing--Should-You-Use-Article-Submission-Software.html]Article Marketing - Should You Use Article Submission Software?[/url]

    Related Articles:

    Comparing Forums to Other Internet Communication Methods

    Home Sellers Ask: Why Doesn't My Home Sell?

    Lesser Known Facts About Home Equity Loans

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com